These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4113156)

  • 21. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
    Morton DL; Goldman L; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
    [No Abstract]   [Full Text] [Related]  

  • 22. Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma.
    Hanna MG; Tennant RW; Yuhas JM; Clapp NK; Batzing BL; Snodgrass MJ
    Cancer Res; 1972 Oct; 32(10):2226-34. PubMed ID: 4117035
    [No Abstract]   [Full Text] [Related]  

  • 23. Serologic cross-reactivity between H-2 and HL-A antigens. I. Specific reactivity of rabbit anti-HL-A sera against murine cells.
    Götze D; Ferrone S; Reisfeld RA
    J Immunol; 1972 Sep; 109(3):439-50. PubMed ID: 4115540
    [No Abstract]   [Full Text] [Related]  

  • 24. Resistance to non-strain-specific variant tumor cells by H-2 allogeneic mice receiving strain-specific cells.
    Forman J; Ketchel MM
    J Natl Cancer Inst; 1972 Apr; 48(4):933-9. PubMed ID: 5023691
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible inhibition of lymphocyte-mediated cytotoxicity by cytochalasin B.
    Cerottini JC; Brunner KT
    Nat New Biol; 1972 Jun; 237(78):272-3. PubMed ID: 4504462
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytotoxic antibodies and lymphocytes induced by orthotopic tooth bud allografts in mice.
    Riviere GR
    J Immunol; 1974 Feb; 112(2):776-82. PubMed ID: 4205208
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 28. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses.
    Springer GF; Desai PR
    Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cyclic AMP in the cytolytic activity of lymphocytes.
    Henney CS; Lichtenstein LM
    J Immunol; 1971 Aug; 107(2):610-2. PubMed ID: 4328013
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 31. Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):441-55. PubMed ID: 4137937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic homology between H-2 and HL-A system.
    David CS; Klein J; Shreffler DC
    Transplant Proc; 1973 Mar; 5(1):461-6. PubMed ID: 4633089
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 36. Further characterization of soluble mouse and human transplantation antigens.
    Summerell JM; Davies DA
    Transplant Proc; 1969 Mar; 1(1):479-82. PubMed ID: 4109220
    [No Abstract]   [Full Text] [Related]  

  • 37. Phagocytic cells as effectors in a cell-mediated immunity system.
    Dennert G; Lennox ES
    J Immunol; 1973 Dec; 111(6):1844-54. PubMed ID: 4543031
    [No Abstract]   [Full Text] [Related]  

  • 38. Rhesus lymphocyte alloantigens. II. Serologic, genetic, and chemical characteristics.
    Rogentine GN; Merritt CB; Vaal LA; Ellis EB; Darrow CC
    Transplant Proc; 1972 Mar; 4(1):21-31. PubMed ID: 4110959
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immune response in vitro. I. A new in vitro system for the generation of cell-mediated cytotoxic activity.
    Wagner H; Feldmann M
    Cell Immunol; 1972 Mar; 3(3):405-20. PubMed ID: 4401190
    [No Abstract]   [Full Text] [Related]  

  • 40. On the specificity of cell-mediated cytotoxicity in vitro.
    Svedmyr EA; Hodes RJ
    Cell Immunol; 1970 Dec; 1(6):644-54. PubMed ID: 5523545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.